Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.640
-0.210 (-5.45%)
At close: May 15, 2026, 4:00 PM EDT
3.610
-0.030 (-0.82%)
After-hours: May 15, 2026, 7:17 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $87.88 million as of May 15, 2026. Its market cap has decreased by -20.50% in one year.
Market Cap
87.88M
Enterprise Value
93.51M
1-Year Change
-20.50%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $87.88M, an increase of 39.25%. That is a compound annual growth rate of 5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 87.88M | -36.22% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 572.63M |
| Fulgent Genetics | 459.81M |
| Myriad Genetics | 341.90M |
| Prenetics Global | 296.01M |
| Insight Molecular Diagnostics | 207.29M |
| Burning Rock Biotech | 195.74M |
| Biodesix | 149.18M |
| FONAR | 123.64M |